rZIKV/D4Δ30-713

live attenuated Zika vaccine · National Institute of Allergy and Infectious Diseases (NIAID)

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for rZIKV/D4Δ30-713, covering 2025-08-05 to 2025-08-05. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Immunogenicity of the Live Attenuated Zika Vaccine rZIKV/D4Δ30-713 in Flavivirus-naïve Adults [Phase 1]

See pricing